- Filed
- Dec 5, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Nov 30, 2024 | 38.82M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2024 | 39.7M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2024 | 39.96M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 41.09M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 41.28M sh |
| Stock Repurchased | Q2 2025 · Oct 31, 2024 | $99.25M |
| Stock Repurchased | Q2 2025 · Oct 31, 2023 | $75.36M |
| Capex | Q2 2025 · Oct 31, 2024 | $23.05M |
| Capex | Q2 2025 · Oct 31, 2023 | $29.55M |
| Operating Cash Flow | Q2 2025 · Oct 31, 2024 | $92.66M |
| Operating Cash Flow | Q2 2025 · Oct 31, 2023 | $124.75M |
| Cash And Equivalents | Q2 2025 · Oct 31, 2024 | $83.93M |
| Cash And Equivalents | Q2 2025 · Apr 30, 2024 | $166.15M |
| Stockholders Equity | Q2 2025 · Oct 31, 2024 | $1.47B |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | $1.47B |
| Stockholders Equity | Q2 2025 · Apr 30, 2024 | $1.46B |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | $1.38B |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $1.35B |
| Stockholders Equity | Q2 2025 · Apr 30, 2023 | $1.27B |
| Current Liabilities | Q2 2025 · Oct 31, 2024 | $748.7M |
| Current Liabilities | Q2 2025 · Apr 30, 2024 | $757.05M |
| Total Liabilities | Q2 2025 · Oct 31, 2024 | $2.55B |
| Total Liabilities | Q2 2025 · Apr 30, 2024 | $2.3B |
| Current Assets | Q2 2025 · Oct 31, 2024 | $1.67B |
| Current Assets | Q2 2025 · Apr 30, 2024 | $1.64B |
| Total Assets | Q2 2025 · Oct 31, 2024 | $4.02B |
| Total Assets | Q2 2025 · Apr 30, 2024 | $3.76B |
| Eps Diluted | Q2 2025 · Oct 31, 2024 | $1.35 |
| Eps Diluted | Q2 2025 · Oct 31, 2024 | $2.77 |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | $1.97 |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | $4.06 |
| Eps Basic | Q2 2025 · Oct 31, 2024 | $1.37 |
| Eps Basic | Q2 2025 · Oct 31, 2024 | $2.82 |
| Eps Basic | Q2 2025 · Oct 31, 2023 | $2.00 |
| Eps Basic | Q2 2025 · Oct 31, 2023 | $4.13 |
| Sga Expense | Q2 2025 · Oct 31, 2024 | $324.23M |
| Sga Expense | Q2 2025 · Oct 31, 2024 | $639.38M |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $300.89M |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $587.69M |
| Net Income | Q2 2025 · Oct 31, 2024 | $53.54M |
| Net Income | Q2 2025 · Oct 31, 2024 | $110.78M |
| Net Income | Q2 2025 · Jul 31, 2024 | $57.25M |
| Net Income | Q2 2025 · Oct 31, 2023 | $80.96M |
| Net Income | Q2 2025 · Oct 31, 2023 | $167.79M |
| Net Income | Q2 2025 · Jul 31, 2023 | $86.83M |
| Operating Income | Q2 2025 · Oct 31, 2024 | $94.82M |
| Operating Income | Q2 2025 · Oct 31, 2024 | $193.2M |
| Operating Income | Q2 2025 · Oct 31, 2023 | $124.8M |
| Operating Income | Q2 2025 · Oct 31, 2023 | $256.54M |
| Gross Profit | Q2 2025 · Oct 31, 2024 | $461.13M |
| Gross Profit | Q2 2025 · Oct 31, 2024 | $912.69M |
| Gross Profit | Q2 2025 · Oct 31, 2023 | $458.63M |
| Gross Profit | Q2 2025 · Oct 31, 2023 | $909.18M |
| Revenue | Q2 2025 · Oct 31, 2024 | $1.47B |
| Revenue | Q2 2025 · Oct 31, 2024 | $2.92B |
| Revenue | Q2 2025 · Oct 31, 2023 | $1.42B |
| Revenue | Q2 2025 · Oct 31, 2023 | $2.83B |